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Abstract
We derive new variance formulas for inference on a general class of estimands of causal
average treatment effects in a Randomized Control Trial (RCT). We demonstrate the appli-
cability of the new theoretical results using an empirical application with hundreds of online
experiments with an average sample size of approximately one hundred million observations
per experiment. We generalize Robins (1988) and show that when the estimand of interest is
the Sample Average Treatment Effect of the Treated (SATT, or SATC for controls), a con-
sistent variance estimator exists. Although these estimands are equal to the Sample Average
Treatment Effect (SATE) in expectation, potentially large differences in both accuracy and
coverage can occur by the change of estimand, even asymptotically. Inference on SATE, even
using a conservative confidence interval, provides incorrect coverage of SATT or SATC. We
derive the variance and limiting distribution of a new and general class of estimands—any
mixing between SATT and SATC—of which SATE is a specific case. An R package, estCI,
that implements all the proposed estimation procedures is available.
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1 Introduction
The Neyman variance estimator is the most commonly used variance estimator in randomized
experiments (Imbens and Rubin, 2015). Under the super-population model, it is a consistent
estimator for the variance of the difference-in-means, and this probably accounts for its popular-
ity. However, under Neyman’s finite population model, a consistent variance estimator for the
difference-in-means does not exist (Neyman, 1923, 1990), and Neyman’s variance estimator is con-
servative. Sharper, albeit still conservative, variance estimators exist (Aronow et al., 2014), but
they are not often used.
To estimate the Sample Average Treatment Effect (SATE), researchers use the limiting distri-
bution of the difference-in-means recentered around SATE. We show that changing the estimand
and recentering the difference-in-means limiting distribution with respect to the Sample Average
Treatment Effect for the Treated (SATT, or SATC for controls) allows one to obtain a consistent
non-conservative variance estimator. Consequently, recentering with respect to SATT (or SATC)
can yield a prediction interval (PI) for SATT (or SATC) that is substantially different from a con-
fidence interval (CI) for SATE. It follows that inference on SATE has incorrect coverage and/or
is inefficient for the estimation of SATT (or SATC).1 The key result of the paper is the derivation
of valid inference on a new and general class of causal estimands that results from any mixing
between SATT and SATC. In addition, we present a plug-in estimator for the mixing between
these two estimands that maximizes the accuracy – minimizes the variance – of the recentered
difference-in-means estimator. We call this causal estimand the Sample Average Treatment Effect
Optimal (SATO). SATE is a specific case of this general class in which the weighting between
SATT and SATC is done by the probability of treatment assignment. SATO is also equal to SATE
under a constant/homogeneous treatment effect model.2
The objective of the paper is to develop limiting distribution results for inference on sample
1This holds even though SATE, SATT, and SATC are equal in expectation and the difference-in-means is used
to estimate all three estimands. Note that under the super-population model, there is no difference between the
equivalent three population estimands, as the Population Average Treatment Effect (PATE) and the Population
Average Treatment Effect of the Treated (PATT) are equal when the treatment assignment is done at random.
2A related literature discusses the idea of an optimal estimand in terms of covariate balance in observational
studies (Crump et al., 2009; Li et al., 2016). Crump et al. (2009) suggested a procedure for choosing the optimal
estimand in observational studies where there is limited overlap in the covariates. The population overlap issue
does not arise in randomized experiments.
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average treatment effects (e.g., SATE, SATT). Imbens (2004) made explicit the difference between
SATE/PATE and SATT/PATT regarding inference, and noted that “[w]ithout further assump-
tions, the sample contains no information about the PATE beyond the SATE.” Therefore, sample
estimands are often of direct interest because one does not wish to make additional assumptions.
Inference on SATO yields a PI that has correct coverage (of SATO) and is substantially shorter,
more accurate, than a CI for SATE. The heterogeneity in the response of different units to the
treatment is the driving force behind the gain in accuracy. The change of estimand yields a recen-
tered difference-in-means test statistic that is sensitive to differences in the variance of the treated
and control units, and not only to the mean impact of the treatment. Our approach detects treat-
ment effect heterogeneity by changing the estimand (and corresponding variance formulas), while
keeping fixed the test statistic. Detecting and testing for heterogeneity in the treatment effect is
of increasing importance to applied researchers (Ding et al., 2016).
Furthermore, in some applications the estimand of interest is SATT and using a CI for SATE
is inaccurate. An example of when SATT can be the estimand of interest is an attributable
treatment effect model in which the treatment effect varies across units (Rosenbaum, 2001; Feng
et al., 2014; Keele et al., 2017). In general, PIs for SATT are not guaranteed to have correct
coverage of SATE. We provide analytical and simulation based evidence for when a PI for SATT
has approximately correct coverage of SATE and when it does not. The key factor behind the
differences is the variance of the treatment effect distribution. As the impacts of the treatment
are more heterogeneous, inference on SATE differs from inference on SATO.
Our possibly surprising results do have an intuitive interpretation: unlike in the case of the
super-population model in which PATE equals PATT and PATC, in the case of Neyman’s finite
sample model, the three estimands differ from each other and each recentering choice yields a
different variance expression for the limiting distribution of the recentered difference-in-means.
Accuracy differences between inference on SATT relative to inference on SATE come from two
channels. First, in the case of SATT (and SATC), one does not need to use conservative bounds
for the variance estimator as it is point-identified. Second, the change of estimand from SATE
to SATT (or SATC) changes the variance of the recentered difference-in-means. We discuss and
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decompose the conditions for accuracy gains from each one of these channels. Robins (1988)
studied this phenomenon for the special case of binary outcomes. He emphasized that a CI for
SATE does not yield correct coverage of SATT (or STAC). We extend his result in various ways,
including by providing results for non-binary outcomes and providing conditions under which the
SATT and SATC prediction intervals yield gains in accuracy. Unlike Robins, we discuss inference
on possible mixes between SATT and SATC and provide a criterion for a plug-in estimator for the
optimal mixing between the two estimands.
Our results also extend Rigdon and Hudgens (2015), who showed that PIs for SATT (and
SATC) can be combined to construct a CI for SATE in the context of binary outcomes. We
generalize their result to the case of non-binary outcomes. In addition, we show that when us-
ing the difference-in-means test statistic, combining PIs for SATT and SATC yields the exact
same conservative CI for SATE as one would have gotten by using a bound for the variance of
the difference-in-means, which assumes that the correlation between potential outcomes is one.
More efficient CIs can be constructed directly using sharper bounds on the unobserved correla-
tion between potential outcomes (Aronow et al., 2014). Taken together, our results prove that as
long as the test statistic is the difference-in-means, combining separate PIs for SATT and SATC,
which have been derived in a non-conservative procedure, does not allow one to construct a CI
for SATE that is more efficient than existing procedures that use conservative variance estimators
and directly conduct inference on SATE.
Inference on SATT and SATC may also be of interest even when the primary parameter of
interest is SATE. SATT represents the effect of the treatment on the units that have been as-
signed/exposed to it, and SATC represents the effect of the treatment on the units that have not
been exposed to it under the observed treatment allocation. To infer whether the treatment had
an effect on average, the key parameter of interest is SATT. However, in order to infer whether
treatment will have an average effect if applied to all the sample units, information on both SATT
and SATC is needed. The difference in PIs for each of these estimands is a diagnostic tool for
understanding how much of the uncertainty about SATE arises from uncertainty about SATT
and how much of it arises from our uncertainty about whether the treatment would have had
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an effect on the controls (SATC). Decomposing the uncertainty over the SATE can be used as a
diagnostic tool for understanding the effects of an intervention, especially in medical trials where
heterogeneity in treatment effects is common.
The remainder of this paper is organized as follows. Section (2) presents an illustrative data
example. Section (3) describes the theoretical framework, definitions, and notation that are used
throughout the paper. Section (4) describes the key theoretical results of the paper. Section
(5) provides Monte Carlo simulations from three different data generating processes. Section
(6) extends some of the theoretical results to the super-population sampling model. Section (7)
mentions several notes and remarks about the theoretical results and possible extensions. Section
(8) discusses the main empirical data application that consists of hundreds of online experiments
with millions of observations. Section (9) concludes.
2 Illustrative example
Following Rosenbaum (2001), we use data from Tunca and Egeli (1996) who studied the effect
of benzene exposure on cytogenetic changes over time. Rosenbaum analyzed this data under an
attributable treatment effect model in which the estimand of interest is SATT. The treated group
(m = 50) is shoe workers in the area of Bursa, Turkey, and the control group (N − m = 20)
is residents of Bursa area who were not exposed to benzene. Although the treatment was not
assigned at random because this is an observational study, for illustrative purposes we follow
previous researchers and assume that the treatment assignment was unconfounded.
Figure (1) shows a CI (SATE) and PIs (SATT and SATC) for the sample average treatment
effects. The PI for SATT is 27% shorter, than a CI for the SATE, while the PI for SATC is
55% longer. The figure demonstrates that in this example SATT is more accurately estimated
than SATE, which has a meaningful interpretation. It implies that there is less uncertainty about
whether the treatment had an effect, and more uncertainty about the effect the treatment will
have if expanded to the units that are currently under the control regime.3
In this example if the researcher is interested in SATT, then a CI for SATE will be overly
3Note that, SATE is a weighted average of SATT and SATC by the probability of treatment assignment.
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conservative and inefficient. However, if the estimand of interest is SATC, then a CI for SATE
will have incorrect coverage and will be too short; i.e., it will over reject the null hypothesis that
SATC is equal to zero.
In what follows we derive analytical results for inference on any weighting between SATT and
SATC, which SATE is a special case of. The optimal weighting, in terms of accuracy, between the
two estimands depends on the variance of the units under the control and treatment regimes and
the correlation between potential outcomes. In the simulations and the main empirical application
we show how to conduct inference on an estimand that is a mix between SATT and SATC and
that it can detect treatment effect heterogeneity even when SATE is equal to zero.
Figure 1: Confidence/prediction intervals for average treatment effects (Tunca and
Egeli, 1996)
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3 Setting, definitions and notation
We follow Neyman’s finite population causal model. Consider a fixed finite population of N ≥ 4
units and two dimensions, Y (0) and Y (1):
ΠN = {(Y (0)1N , Y (1)1N), (Y (0)2N , Y (1)2N), . . . , (Y (0)NN , Y (1)NN)} (1)
The researcher observes a random sample of m units from the finite population:
Π1N = {Y (1)1N , Y (1)2N , . . . , Y (1)NN} (2)
and the vector of treatment indicators, T = (T1, . . . , TN), represents the m units that are ran-
domly sampled to the treatment group.4 The remaining N − m units are assigned to the con-
trol group and they form a random sample of N − m units from the finite population Π0N =
{Y (0)1N , Y (0)2N , . . . , Y (0)NN}, which is represented by the vector of indicators, (1− T1, . . . , 1− TN).
The probability of each unit being assigned to the treatment regime is p = m
N
and the correlation
between the treatment assignment of each two units is negative:
Cov (Ti, Tj) = p ·
(
m− 1
N − 1 − p
)
< 0 (3)
Let Yi be the outcome of interest for unit i, which is a function of Y (T ). We assume SUTVA
(Holland, 1986) is satisfied:
Yi(T ) = Yi(Ti) (4)
and Ti is assigned at random:
Y (1), Y (0) ⊥ T (5)
4We study the classic Neyman causal model for a finite population. For a review of the framework and the classic
CLT results under the finite population model, see Li and Ding (2016). Note that, the randomization model implies
that the number of treated units, m, is a fixed number and not a random variable. The only random component is
the treatment indicators.
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Let τi denote the treatment effect on unit i, Yi(1)−Yi(0), and let the vector of treatment effects
in the finite population be denoted by τ = Y (1) − Y (0). The researcher might be interested in
conducting inference on several possible average treatment effect estimands:
SATE =
1
N
·
N∑
i=1
τi (6)
SATT =
1
m
·
N∑
i=1
τi · Ti, where m =
N∑
i=1
Ti (7)
SATC =
1
N −m ·
N∑
i=1
τi · (1− Ti) (8)
We do not impose any parametric assumptions on the relationship between Y (1) and Y (0), and
allow τ to vary across units. It is important to note that unlike SATE, both SATT and SATC are
random variables, even conditional on the sample, as they are a function of T . Because SATT is
a random variable, a random interval that contains SATT a with probability of 1 − α is usually
referred to as a prediction interval (PI) or, in Bayesian terminology, a credible interval, rather than
a CI. We are not the first ones to discuss inference on a causal estimand that is a random variable
(Robins, 1988; Bowers and Hansen, 2009).
4 Theory
In this section we discuss how to conduct inference, without parametric or distributional assump-
tions, on a general class of average treatment effect estimands:
ωSATT + (1− ω)SATC (9)
We first present theoretical results on inference about SATT (or SATC) that generalize Robins
(1988) to non-binary and continuous outcomes. Next we conduct a comparison between inference
on SATE and SATT in terms of accuracy and coverage (i.e., type I error). We show that a PI for
SATT (or SATC) can be substantially different (smaller or larger) than a CI for SATE, and we
decompose the differences to those that result from a change of estimand and those that are the
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result of being forced to use a conservative variance estimator when conducting inference on SATE.
At the end of this section we derive the accuracy-maximizing estimand. This is the mix between
SATT and SATC that can be estimated with the highest level of precision while holding fixed the
test statistic. SATE is a specific case of the general class of estimands described in equation (9)
when ω = p.
4.1 Inference on SATT (and SATC) relative to SATE
The classic estimator for SATE (and SATT) is the difference-in-means between the outcomes of
units under the two treatment regimes. For notational convenience, denote the difference-in-means
estimator by tdiff:
tdiff ≡ 1
m
N∑
i=1
Yi · Ti − 1
N −m
N∑
i=1
Yi · (1− Ti) (10)
Lemma (1) shows that the difference-in-means can be decomposed to three terms of which only
two depends on τ . In equation (11), the first expression is a function of Yi(0) and Ti and is a
random variable, the second is a function of Yi(0) and is not a random quantity, and the third is
SATT. Lemma (1) motivates the use of tdiff for estimating SATT (or SATC). When recentering
tdiff w.r.t. SATE the variance of the recentered estimator does not change; however, recentering
w.r.t. SATT (or SATC) does change the variance calculations. This raises the question of whether
inference on SATT (or SATC) has correct coverage of SATE and vice versa. Next we address this
question both analytically and using Monte Carlo simulations.
Lemma 1. The difference-in-means test statistic tdiff can be decomposed into three expressions:
tdiff (Y ,T ) =
N
m · (N −m) ·
N∑
i=1
Yi(0) · Ti − 1
N −m ·
N∑
i=1
Yi(0) + SATT (11)
or
tdiff (Y ,T ) =
N
m · (N −m) ·
N∑
i=1
Yi(1) · Ti − 1
N −m ·
N∑
i=1
Yi(1) + SATC
9
See Appendix (B) for the proof.
Lemma (2) describes the variance of tdiff when it is recentered with respect to different causal
estimands of interest. The variance of tdiff − SATE contains the parameter ρ, which cannot be
observed and must be bound when conducting inference. Lemma (1) illustrates how by changing
the estimand from SATE to SATT (or SATC), still using the difference-in-means test statistic, it
is possible to conduct inference without needing to either know or bound ρ.
Lemma 2. The variance of the difference-in-means when recentered w.r.t. SATE, SATT or SATC
is
Var (tdiff − SATE) = 1
N · (1− p) · p ·
[
p2 · σ20 + (1− p)2 · σ21 + 2p(1− p) · ρ · σ0 · σ1
]
Var (tdiff − SATT) = 1
p · (1− p) ·N · σ
2
0
Var (tdiff − SATC) = 1
p · (1− p) ·N · σ
2
1
where ρ ≡ Cov(Y (1),Y (0))
σ0·σ1 is the correlation between the potential outcomes under the treatment and
control regimes, and σ2j is defined as σ
2
j =
∑N
i=1(Y (j)i−Y¯ (j))
2
N−1 . See Appendix (C) for the proof.
The tdiff− SATT can be more accurately estimated relative to the tdiff− SATE when σ1σ0 > 1, ρ
is sufficiently high, and p is not too high (e.g., p = 1/2). Theorem (4.1) shows that regardless of
the value of σ1
σ0
there is a threshold level of ρ that below it Var (tdiff − SATE) ≤ Var (tdiff − SATT)
and above which Var (tdiff − SATE) > Var (tdiff − SATT). Notice that according to Theorem (4.1),
it is simple to empirically test whether ρ¯ is negative. All that is needed is to conduct a one-sided
hypothesis test of the null:
H0 :
σ1
σ0
≤
√
1− p2
(1− p)2
and if the null hypothesis is rejected we can infer that ρ¯ < 0.
Theorem 4.1. For all σ0 and σ1 such that σ0 < σ1:
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1. There exists a threshold level of ρ, ρ¯ such that
ρ ≤ ρ¯⇒ Var (tdiff − SATE) ≤ Var (tdiff − SATT)
ρ > ρ¯⇒ Var (tdiff − SATE) > Var (tdiff − SATT)
2. When σ1
σ0
>
√
1−p2
(1−p)2 then, ρ¯ < 0.
See Appendix (D) for the proof.
In practice, the correlation between potential outcomes is not observed and to estimate Var (tdiff − SATE)
it is required to use a bound for ρ. The most commonly used estimator was proposed by Neyman
and it ignores the correlation component all together. It can be re-written as:
VNeyman =
1
m
σ21 +
1
N −mσ
2
0
=
1
N · p · (1− p)
(
σ21(1− p) + σ20p
)
. (12)
This variance estimator is a consistent estimator for the variance of the difference-in-means under
the super-population sampling model, and it can be used to conduct inference on the Population
Average Treatment Effect (PATE). It also corresponds to Neyman’s second variance estimator
when the estimand is SATE (Neyman, 1923, 1990). A less conservative variance estimator for the
difference-in-means bounds ρ at 1:
Vρ=1 =
1
m
σ21 +
1
N −mσ
2
0 −
(σ1 − σ0)2
n
=
1
N · (1− p) · p (p · σ0 + (1− p) · σ1)
2 (13)
Theorem 4.2. (Asymptotic distribution of tdiff−SATT ) The difference-in-means recentered w.r.t.
SATT follows a standard Normal distribution under two regularity conditions. When the following
two conditions are satisfied:
N −m→∞, m→∞ and
max
1≤i≤N
(
Y (0)Ni − Y¯ (0)N
)2
∑N
i=1
(
Y (0)Ni − Y¯ (0)N
)2 ·max(N −mm , mN −m
)
→ 0
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then
tdiff − SATT√
Var (tdiff − SATT)
d→ N(0, 1) (14)
see Appendix (E) for the proof.5
Therefore, a 1− α prediction interval for SATT is
[
tdiff − z1−α/2 · σˆ0 ·
√
k(N,m), tdiff + z1−α/2 · σˆ0 ·
√
k(N,m)
]
(15)
where
k(N,m) =
1
p · (1− p) ·N
Theorem (4.2) establishes that the limiting distribution of the tdiff−SATT, when standardized
using the variance formulas in Lemma (2), is standard Normal. An equivalent derivation of the
limiting distribution can be carried out for SATC. The theorem for tdiff−SATC follows immediately
using an analog proof.
Rigdon and Hudgens (2015) showed how to derive a CI for SATE by combining two PIs for
SATT and SATC. They focused on binary outcomes for which PIs have been derived using past
theoretical results (Robins, 1988; Rosenbaum, 2001). Theorem (4.3) provides two key results.
First, it is a generalization of Theorem (1) in Rigdon and Hudgens (2015) and shows how a CI for
SATE can be constructed in any randomized control trial regardless of whether the outcomes are
binary or continuous. This part of the theorem follows directly from the derivations in Rigdon and
Hudgens (2015). Second, it shows that combining PIs for SATT and SATC using a Bonferroni-
type adjustment, as was done by Rigdon and Hudgens, yields exactly the same CI as when one
constructs a CI for SATE directly and uses a conservative variance estimator that bounds rho at 1,
Vρ=1. Theorem (4.3) implies that combining PIs for SATT and SATC yields a more conservative
CI than using a CI based on a sharper bound for ρ, such as that of Aronow et al. (2014).
5These are not the weakest possible conditions.
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Theorem 4.3. Let [LSATT, USATT] and [LSATC, USATC] be PIs for SATT and SATC according to
the variance formulas in Lemma (2); then a CI for SATE is
[p · LSATT + (1− p) · LSATC, p · USATT + (1− p) · USATC]
and is equal to
[
tdiff − z1−α/2 ·
√
Vˆρ=1, tdiff + z1−α/2 ·
√
Vˆρ=1
]
See Appendix (F) for the proof.
Theorem 4.4. When σ1 6= σ0, a PI for either SATT or SATC is shorter than a CI for SATE that
uses either VNeyman or Vρ=1.
See Appendix (G) for the proof.
According to Theorem (4.4), whenever σ0 < σ1 (σ0 > σ1), a PI for SATT (SATC) is shorter
than a CI for SATE using Neyman’s variance estimator. The gain in terms of interval length (in
%) is
1− 1√(
σ21
σ20
(1− p) + p
) (16)
and the gains are decreasing with respect to p.
The interval length gains (in percentages) of a PI for SATT relative to a CI for SATE are illus-
trated in Figure (2). In a balanced design, p = 1
2
, with a variance ratio of two, the length/accuracy
gain is 18.35% relative to a CI for SATE that is based on Neyman’s variance estimator. Figure (2)
shows the accuracy gains from estimating SATT instead of SATE for different levels of p, which
can be substantial.
Note that Theorem (4.4) does not cover other estimators for the variance of Var (tdiff − SATE),
such as that of Aronow et al. (2014). CIs based on these other variance estimators may be shorter
than our PIs even when σ1 6= σ0. To address these variance estimators, we derive the accuracy
gains for a more general case in which ρ can be bounded by ρ∗, ρ ≤ ρ∗. As the variance of
13
Figure 2: Percentage gains from a PI for SATT instead of a CI for SATE
l
l
l
l
l
l
l
l
l l
0
20
40
60
2.
5
5.
0
7.
5
10
.0
Variance ratio (σ12 σ02)
Le
ng
th
 g
ai
n 
(in
 pe
rce
nta
ge
s )
 
Treatment probability: l 0.2 0.5 0.8
Var (tdiff − SATE) is increasing w.r.t. ρ, it follows that substituting ρ∗ with ρ yields a conservative
variance estimator that is smaller than Neyman’s variance estimator. The idea of substituting a
bound of ρ instead of the true parameter value was proposed before in the literature (Reichardt
and Gallob, 1999; Aronow et al., 2014). The percentage gain in terms of CI length is
1− 1√
p2 + (1− p)2 ·
(
σ1
σ0
)2
+ 2p(1− p) · ρ∗ · ·σ1
σ0
To obtain intuition about how recentering the difference-in-means w.r.t. SATT provides an
accuracy gain, it is useful to decompose the variance of the difference-in-means. The decomposition
in equation (17) shows that when recentering w.r.t. SATT we cancel two of the elements in the
variance of the difference-in-means, Var (SATT) and Cov
(
SATT, N
m(N−m) ·
∑N
i=1 Y (0)Ti
)
, and in
doing so reduce the uncertainty.
Var (tdiff − SATE) = Var (SATT) + Var
(
N
m(N −m) ·
N∑
i=1
Y (0)Ti
)
+ 2 · Cov
(
SATT,
N
m(N −m) ·
N∑
i=1
Y (0)Ti
)
(17)
To understand why inference on SATE can provide incorrect coverage of SATT (or SATC), it
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is useful to look at the mean square distance between the two estimands:
MSE(SATE, SATT) =
1− p
m
· σ2τ (18)
see Appendix (A) for the proof. The differences between conducting inference on SATE or SATT
does increase with the heterogeneity of the treatment effect. Given a fixed and bounded value of
σ2τ <∞, those difference will converges to zero as m→∞.
To illustrate how SATT and SATE can differ substantially, consider the following extreme
example. There is a finite population of four units (see Table (1)) of which two are assigned to the
treatment regime and the other two to the control regime. SATE is exactly zero in this example;
however, SATT can be negative, positive, or zero depending on which units are allocated to the
treatment group. In this example using inference on SATE (or SATT) to approximate inference
on the SATT (or SATE) is misleading. However, inference on SATT can be valuable; and an
estimand of interest in its own.
Table 1: Example of when SATT can substantially differ from SATE
Unit Y (1) Y (0)
1 1 0
2 -1 0
3 -100 0
4 100 0
4.2 Inference a general class of average treatment effects
In this section we derive inference for the Sample Average Treatment Effect Optimal (SATO),
which is the weighting of SATT and SATC that minimizes MSE. The inference is conditional on
the sample and uses the difference-in-means test statistics. Formally, SATO is defined as
SATO ≡ ω∗ · SATT + (1− ω∗) · SATC
s.t.
ω∗ = argmin
ω
Var
(
ˆ¯Y1 − ˆ¯Y0 − SATO
)
= argmin
ω
MSE
(
ˆ¯Y1 − ˆ¯Y0 − SATO, 0
)
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Lemma 3. The variance of the difference-in-means when recentered w.r.t. any choice of weighting
between SATT and SATC, Var (tdiff − (ωSATT + (1− ω)SATC)), is
1
Np(1− p)
[
p2σ20 + (1− p)2σ21 + 2p(1− p) · ρσ0σ1
]
+
σ2τ
N − 1 ·
[
ω2 · 1− p
p
+ (1− ω)2 · p
1− p − 2ω(1− ω)
]
− 2 ·
[
ω
(N − 1)p
[
σ21 − ρσ1σ0
]− 1
N − 1 · σ
2
τ +
(1− ω)
(N − 1)(1− p)
[
σ20 − ρσ1σ0
]]
See Appendix (I) for the proof.
Lemma (3) presents the variance of the difference-in-means when it is recentered w.r.t. ωSATT+
(1 − ω)SATC for any choice of ω. It follows immediately from Lemma (3), that the optimal
accuracy-maximizing value of ω is
ω∗ =
(
σ1
σ0
)2
− ρ · σ1
σ0(
σ1
σ0
)2
+ 1− 2ρ
(
σ1
σ0
)
The optimal choice of ω depends on two parameters, ρ and σ1
σ0
, and is independent of p. This
is in stark contrast to SATE, which is the weighting of SATT and SATC according only to the
probability of treatment assignment. Figure (3) illustrates how the value of ω changes depending on
ρ and σ1
σ0
. Two clear patterns stand out. First, the weight that is assigned to SATT is monotonically
increasing w.r.t. the variance ratio, σ1
σ0
. Second, the relationship between ω∗ and ρ is ambiguous
and depends on σ1
σ0
. When σ1
σ0
> 0, as ↑ ρ, the weight assigned to SATT increases, and the opposite
is true when σ1
σ0
< 0.
A key question is under what conditions SATE is equal to SATO, which is equivalent to asking
whether SATE can ever be the estimand that is estimated most accurately. Two scenarios in
which SATO coincides with SATE are (i) a constant treatment effect model and (ii) when σ1 = σ0
and p = 1/2. When the variance ratio is equal to 1, the optimal weighting between SATT and
SATC is half and half (ω = 0.5). Equality of variance between treatment and control units does
not imply that SATO collapses to SATE. The right plot of Figure (4) shows the accuracy gain
of SATO relative to SATE for different values of ρ and p. SATO can be estimated at a higher
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Figure 3: Optimal ω weight of SATT in SATO for different σ1
σ0
and ρ
0.00
0.25
0.50
0.75
1.00
0.0 0.5 1.0 1.5 2.0
Variance ratio (σ12 σ02)
O
m
eg
a 
( w
e
ig
ht
 o
n 
SA
TT
 ) 
cor(Y(1),Y(0)): 
−1
0
1
Notes: The above figure describes the relationship between the variance ratio of treated and control units
(σ1σ0 ) and the weight which is assigned to SATT in SATO for three different values of ρ.
degree of accuracy for most levels of ρ and for any p 6= 1/2, even when σ1 = σ0. The left plot of
Figure (4) compares the accuracy of inference on SATE to a mixing between SATT and SATC –
not SATO as ω∗ is not used – for a variety of different ω weights and three values of ρ. SATE
can be estimated more accurately than many mixes of SATT and SATC, but it will always – for
a known ρ – be more noisily estimated than SATO. To conclude, it is hard to justify a weighting
of SATT and SATC that will yield the SATE when the objective is to maximize accuracy. SATE
is the only mix of SATT and SATC that yields a parameter and not a random variable.
5 Analytical examples and simulations
5.1 Additive random coefficients model
We consider a simple additive treatment effect model with heterogeneous impacts across units:
Yi(1) = τi + Yi(0) (19)
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Figure 4: The accuracy gain (in percentages) from estimating SATO instead of SATE
when σ1
σ0
= 1 for different values of the treatment assignment probability (p) and the
correlation between potential outcomes (ρ)
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Notes: The left plot describes the relationship between the accuracy gain of conducting inference on a
mixing between SATT and SATC relative to SATE as a function of the weight which is assigned to SATT
(ω) for three different values of ρ. The right plot illustrates the relationship between ρ and the accuracy
gains of a PI for SATO relative to a CI for SATE for three different levels of the probability of treatment
assignment. In both plots the relationships that are described are for the case in which σ1σ0 = 0, which
implies that accuracy gains are not the result of a difference in the variance of the outcome among treated
units relative to the control units.
where τi is a random variable, which for simplicity is assumed not to be correlated with Yi(0), nor
to be correlated with Ti by construction due to the randomization of treatment assignment. The
variance of the treated units is larger by σ2τ , and this generates a potential difference between a CI
for SATE and a PI for SATT. The variance ratio is:
σ2τ
σ20
+ 1
and is increasing with the heterogeneity of the treatment effect. Consider the data-generating
process in (20) with a sample of n = 1, 000 units. We performed 1, 000 draws of samples and
for each one simulated 1, 000 different allocations of the treatment according to p = 1/2. Figure
(5) reports the simulation results. The PIs for SATT are substantially shorter than the CIs for
the SATE; this holds both when using Neyman’s variance estimator and when using a variance
estimator based on a sharp bound for ρ, such as that of Aronow et al. (2014). The comparison to
the CI based on the true ρ parameter shows that the accuracy differences are mainly due to the
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change of estimand, rather than a conservative variance estimator. This is contrary to the binary
outcome example (see below). The simulation is supported by our theoretical results that a change
of estimand has larger accuracy impacts as the variance of the treatment effect is higher. The left
plot in Figure (5) shows that coverage of the PI for SATT w.r.t. both SATT and SATE. As the
treatment effect becomes more heterogeneous the PI for SATT provides worse coverage of SATE
and, vice versa, a CI for SATE provides worse coverage of SATT. In a heterogeneous treatment
effect environment it is required to use variance formulas that guarantee correct coverage of the
estimand of interest, as SATE, SATT, and SATC can differ substantially from one another.
Yi(0) ∼ N(µ = 10, σ20 = 1)
τi ∼ N(µ = 0, σ2τ )
Yi(1) = τi + Yi(1) (20)
Figure 5: Additive and heterogeneous treatment effect (random coefficient) simulation
results: Length and coverage differences
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Notes: The left plot shows the coverage of a PI for SATT w.r.t. SATT and SATE. The coverage of
SATT has correct size and there is no evidence of over rejection of the null hypothesis. On the other
hand, the coverage of SATE becomes worse as the variance of the treatment effect increases. The right
plot illustrates the accuracy gains of using inference on SATT relative to SATE. The PI for SATT is
compared to CIs for SATE based on three different values of ρ. The circles represent the accuracy gains
(in percentages) relative to Neyman’s variance estimator which assumes that ρ = 0. The squares dots
use a sharp bound for ρ that have been derived by Aronow et al. (2014). And the triangles compare the
length of a PI for SATT to a CI for SATE when the true value of ρ is known to the researcher.
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5.2 Binary outcomes
Consider a finite population of size N :
ΠN = {(Y (0)1N , Y (1)1N), (Y (0)2N , Y (1)2N), . . . , (Y (0)NN , Y (1)NN)} (21)
where (Y (0)iN , Y (1)N) ∈ {0, 1}2, and
p0 =
1
N
·
N∑
i=1
Yi(0) and p1 =
1
N
·
N∑
i=1
Yi(1),
The outcome variable is binary and we assume the treatment has a positive effect on average:
0 ≤ p0 ≤ 1/2 and p0 < p1 ≤ 1/2 (22)
These conditions insure that the positive treatment effect increases the variance of the outcomes
among the treated units. SATE is equal to p1 − p0, which implies that when the conditions in
equation (22) are met, the variance of the treated units is strictly higher than that of the controls,
p0(1− p0) < p1(1− p1), and the variance ratio is a function of the treatment effect,
σ21
σ20
=
(p0 + SATE)(1− p0 − SATE)
p0(1− p0) (23)
The accuracy gains are increasing with the treatment effect as long as the treatment generates
a variance increases among the treated units. Figure (6) shows the interval length gains (in
percentages) from using a PI for SATT in the case of a binary outcome. When p0 = 0.1 and
p1 = 0.2, the interval for SATT is lower by 23.3% relative to the standard CI that is based on
Neyman’s variance estimator.
Next we decompose how much of the efficiency gain is due to a change of estimand, and how
much is due to the conservative variance estimation. The lower line (i.e., triangles) in Figure (6)
shows the percentage difference in length relative to a CI for SATE when ρ is known. This CI
is substantially shorter than the ones for SATT, which demonstrates that in this simulation the
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efficiency differences are due to the conservative variance estimation and not because of the change
in estimand. Unlike the random coefficient model above, there are small differences in coverage
under this data-generating model, although, there are differences in accuracy. The binary outcomes
model has less heterogeneity in the treatment effect distribution (i.e., σ2τ is smaller) which mitigates
the differences between the different estimands.
Figure 6: Binary outcome simulation: Length and coverage differences.
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Notes: See the notes in Figure (5).
5.3 Censored outcomes (Tobit model)
Consider a finite population of size N ,
ΠN = {(Y (0)1N , Y (1)1N), (Y (0)2N , Y (1)2N), . . . , (Y (0)NN , Y (1)NN)} (24)
where Y (0) is a continuous outcome and Y (1) is,
Y (1) =
 Y (0) + τ, Y (0) ≥ 0Y (0), Y (0) < 0 and τ > 0
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The above data generating-process implies that the variance of the potential outcomes under
treatment is higher than the variance of units under the control regime:
Var (Y (1)) = σ20 + Pr(Y (0) > 0) · τ · [τ · (1− Pr(Y (0) > 0) + E [Y (0)|Y (0) > 0]− E [Y (0)]] > σ20
and the variance ratio is:
σ21
σ20
= 1 +
Pr(Y (0) > 0) · τ · [τ · (1− Pr(Y (0) > 0) + E [Y (0)|Y (0) > 0]− E [Y (0)]]
σ20
The variance ratio is increasing with respect to τ and there is a potential for accuracy gains by
changing the estimand from SATE to SATT. The simulation results in Figure (7) confirm the above
derivation. Similarly to the random coefficient model the change of estimand is the main cause
of the differences in length. Similarly to the previous simulations, as σ2τ increases the differences
between estimands become more stark and inference for SATT (SATE) has bad coverage w.r.t.
SATE (SATT):
Yi(0) ∼ N(µ = 0, σ20 = 1) (25)
Figure 7: Censored outcome (Tobit) simulation results: Length and coverage differ-
ences
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22
6 Super-population model
In the super-population model the sampling procedure has two steps. First, a sample of N units
is drawn from a super-population, FY (1),Y (0)(·), which can be either finite or infinite. Second, m
units are randomly allocated to the treatment regime and the remaining N −m units are assigned
to the control regime.6 Both the treatment indicator and the potential outcomes are random
variables, and they are independent, due to the random assignment of units to treatment regimes.
SATE, SATT, and SATC are all random variables that are unbiased, and consistent, estimators
of PATE. Under the super-population model the difference-in-means test statistic can be used to
construct a CI for PATE. Neyman’s variance estimator is a consistent estimator for the variance
of the difference-in-means test statistic (Imbens and Rubin, 2015). PATE, PATT, and PATC are
all equal and recentering the difference-in-means w.r.t. PATE is equivalent to recentering it w.r.t.
PATT (or PATC). There are no efficiency gains or inaccuracies in making inference on PATT
instead of PATE.
Next we describe the behavior of the difference-in-means when it is recentered w.r.t. different
sample average treatment effect estimands (e.g., SATE, SATT). The variance of tdiff − SATE is
lower than that of tdiff − PATE:
Var (tdiff − SATE) = Var (tdiff)− 1
N
· σ2τ︸ ︷︷ ︸
Var(SATE)
≤ Var (tdiff) = Var (tdiff − PATE) (26)
and
Var (tdiff) =
σ21(SP)
m
+
σ20(SP)
N −m (27)
where σ2j (SP) (j = 0, 1) denotes the variance of units under treatment regime j in the super-
population. See Appendix (H.1) for a proof of equation (26). In the fixed population case, SATE
is a parameter and not a random variable, which changes when sampling uncertainty is introduced
and the potential outcomes become random variables as well.
6The number of treated and control units is fixed: m is not a random variable.
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Lemma (4) establishes that the variances calculations we derived in Section (4) hold also under
the super-population framework. Although the variance calculations are over repeated samples,
the correlation term between potential outcomes, ρ, does not go away and to conduct inference
on the SATE all the issues we discussed in Section (4) arise here as well. More specifically, the
uncertainty calculation over repeated draws of data cancels the ρ term in the variance of the
difference-in-means test statistic. However, it also introduces a correlation term ρ in the variance
of SATE, which is now a random variable. The two elements cancel each other out and yield a
variance formula that is exactly the same as the one that was derived in Lemma (2).
Lemma 4. Under the super-population model, the variance of the difference-in-means when re-
centered w.r.t. the SATE, SATT, or SATC is
Var (tdiff − SATE) = 1
N · (1− p) · p ·
[
p2 · σ20(SP) + (1− p)2 · σ21(SP) + 2p(1− p) · ρ(SP) · σ0(SP) · σ1(SP)
]
Var (tdiff − SATT) = 1
p · (1− p) ·N · σ
2
0(SP)
Var (tdiff − SATC) = 1
p · (1− p) ·N · σ
2
1(SP)
See Appendix (H.1) for the proof.
7 Comments
Several notes on the previous results and possible extensions are in order.
Remark 1. The previous results can be extended to include covariate adjustment of pre-
treatment characteristics according to the procedure that was proposed by Rosenbaum (2002).
Denote by Xi a 1× p dimensional vector of the pre-treatment characteristics of unit i. The matrix
X has dimensions n × p and each row i contains the pre-treatment characteristics of unit i. It
is common to adjust Yi for Xi for efficiency purposes. Define Y
adjusted
i = Xi(X
′X)−1X ′Yi as the
adjusted/residualized responses. All the results for inference on Yi also apply for inference on
Y adjustedi .
Remark 2. The inference results for SATT (and SATC) can also be extended to different
randomization models. For example, Theorem 7.1 provides variance and limiting distribution
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results for inference on SATT when the treatment assignment is done by random independent
Bernoulli trials. This illustrates how inference on SATT can be derived under random treatment
assignment models that differ from the classic complete randomization mechanism.
Theorem 7.1. (Limiting distribution of tdiff - SATT) When treatment is assigned according to
random independent Bernoulli trials, the standardized and recentered, w.r.t. SATT, difference-in-
means follows a standard Normal distribution under two regularity conditions. When the following
is satisfied:
N −m→∞, m→∞, and σ21, σ20 <∞ (28)
then:
N−m
N
· (tdiff − SATT)√
Var
(
1
m
·∑Ni=1 Yi(0) · Ti)
d→ N(0, 1) (29)
where
Var
(
1
m
·
N∑
i=1
Yi(0) · Ti
)
=
 1m
−
∑N
i=1 Yi(0)·Ti
m2

T
· Σ ·
 1m
−
∑N
i=1 Yi(0)·Ti
m2
 (30)
and
Σ =
 N · p(1− p) [σ20 + E [Y (0)]2] p(1− p) ·N · E [Y (0)]
p(1− p) ·N · E [Y (0)] N · p(1− p)
 (31)
See Appendix (J) for the proof.
Remark 3. The regularity conditions of the above theoretical results will usually be satisfied
in applied research, yet it is important to understand when they will not. For example, imagine a
control regime in which all the individuals die (Yi(0) = 0 ∀i), while under the treatment regime
units have a strictly positive survival probability, E [Y (1)] = p1 and Var (Y (1)) = p1(1 − p1). As
the variance of the control units is strictly lower (zero) than that of the treated units, there are
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potential accuracy gains from estimating SATT instead of SATE. In this scenario as σ20 = 0 the
PI for SATT contains only one point, the difference-in-means estimate, which is clearly wrong.
The example above does not stand in contradiction to Theorem (4.2), as in the above case the
regularity condition of the theorem is not satisfied:
max
1≤i≤N
(
Y (0)Ni − Y¯ (0)N
)2
∑N
i=1
(
Y (0)Ni − Y¯ (0)N
)2 = 00
and 0
0
is not a well-defined expression.
8 Real data application: Online experiments
To better understand the trade-offs in conducting inference on different average treatment effect
estimands, we analyze a sample of online field experiments that have been conducted by a large
internet firm as product improvement tests. Our sample consists of 278 experiments with an
average sample size of approximately one hundred million units per experiment. Many different
outcome metrics are analyzed for various subgroups. The average subgroup consists of 1.1 million
observations, and there are 826 unique outcome metrics across all of the experiments. In total,
twenty-five thousand different treatment effects are estimated. The data analyzed were aggregated
and de-identified.
Figure (8) shows the distribution of the difference-in-means across all of the online experiments.
It is clear that on average, across experiments, the treatment had a zero effect. The distribution
of difference-in-means is tightly centered around zero. However, this does not imply that the
treatment had no effect. Treatment effect heterogeneity can generate positive effects for some units
and negative effects for others that cancel each other on average. Elaborate tests and computations
are difficult to carried out with millions of observations. Inference on SATO provides a simple
solution as it is sensitive to heterogeneous treatment effects and is guaranteed to have correct
coverage and valid inference on SATO. Another advantage of SATO is that for the simple cases
of ρ ∈ {−1, 0, 1}, the change of estimand from SATE to SATO does not require any additional
information for inference. It can be carry out using only aggregate summary statistics that are
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already collected for inference on SATE.
The left plot of Figure (9) replicates Figure (2) in a real empirical application and demonstrates
that variance differences across experiments exist. As the variance ratio
σ21
σ20
increases, the PI for
SATT becomes shorter, and in some cases there can be large variance gains from changing the
estimand to SATO. The left plot of Figure (9) shows the share of experiments in which the null
hypothesis that the estimand is equal to zero was rejected, as a function of the variance ratio. As the
variance ratio departs from one there are substantial efficiency gains to be had from conducting
inference on SATO (with ρ = 1) relative to SATE. The differences in rejection rates between
inference on SATE and SATO are evidence of treatment effect heterogeneity.
Figure 8: Distribution of the difference-in-means across experiments
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Notes: The figure shows the distribution of the raw difference-in-
means over all online experiments in our sample.
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Figure 9: Inference accuracy: A comparison of SATO and SATT to SATE across online
experiments
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Notes: The left plot describes the empirical analogue of Figure (2). It plots the relationship between the
variance ratio in the experiment and the gain in accuracy from conducting inference on SATT relative
to SATE. The right plot compares the rejection rate of the null hypothesis that the estimand of interest
is equal to zero for SATE and SATO when ρ = 1.
9 Discussion
In some applications, the estimand of interest is SATT (or SATC). Making inferences about SATT
(or SATC) using a CI for SATE relies on variance estimators that are not consistent and are
not guaranteed to have correct coverage or be efficient. We derive efficient variance formulas for
inference on a new and general class of estimands derived from any mixing between SATT and
SATC. The variance formulas are used to construct PIs that are non-parametrically guaranteed
to have correct coverage and to be non-conservative – unlike inference on SATE. All inference
procedures discussed in the paper use the difference-in-means as the test statistic, and therefore
have the same point estimates as existing methods. Note that all three estimands, SATE, SATT,
and SATC, are equal in expectation. The key difference is in the variance calculations. In addition,
we present a new diagnostic tool, a decomposition of the uncertainty about the value of SATE
into two components: uncertainty about SATT and about SATC, which both have an intuitive
interpretation.
Taken together, the Monte Carlo simulations demonstrate that: (i) the choice of estimand has
a direct implication on the accuracy of the inference that can be conducted; (ii) using variance
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formulas that have correct size for SATE will not have correct coverage of other sample average
treatment effect estimands such as SATT or SATO. When a researcher is interested in conducting
inference on SATT, she is required to use variance formulas that have correct coverage for this
estimand. Such formulas are derived in the paper.
The application to online experiments is a clear example of a scenario in which the methods
developed in the paper can provide accuracy gains over standard practice. The gains mainly arise
because inference on SATO is sensitive to treatment effect heterogeneity through the variance
calculations. The large potential for accuracy gains emphasizes that researchers and other applied
users should think carefully about which causal estimand they want to conduct inference on. If
the answer is SATE, then they should not use any of the results in this paper; however, if SATO
is also of interest, then large accuracy gains can be obtained by a change of estimand. In addition,
if SATT is the primary object of interest, then variance formulas for inference on SATE will have
incorrect coverage of SATT.
Our results can be used in a variety of empirical applications from medicine and social sciences
to online ad experiments. In many cases one would like to have more accuracy when testing the
null hypothesis of no average treatment effect. This occurs even when, as in the case of digital
experiments, the sample size is large, but the power is limited (Lewis and Rao, 2014). The accuracy
gains we document hold even asymptotically, and could be of special value in massive experiments
because our approach requires computing only summary statistics that are simple to obtain and
easy to compute, and lead to possibly large gains in accuracy.
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Online appendix: Proofs
A Derivation of MSE(SATE,SATT)
MSE(SATE, SATT) = MSE(tdiff − SATE, tdiff − SATT)
= [E [SATE− SATT]]2 + Var (SATT)
= Var (SATT)
=
(
1
m
− 1
N
)
· σ2τ
=
N −m
Nm
· Var (τi) = 1− p
m
· σ2τ
B Proof of Lemma 1
The sum of the responses of the treated units can be decomposed into two components, the sum
of the potential outcomes under control and the sum of the treatment effects.
N∑
i=1
Yi · Ti =
N∑
i=1
Ti · Yi(1) =
N∑
i=1
Ti · Yi(0) +
N∑
i=1
Ti · (Yi(1)− Yi(0)) (32)
⇒ 1
m
·
N∑
i=1
Yi · Ti = 1
m
·
N∑
i=1
Ti · Yi(0) + SATT (33)
We can re-write the difference in means as,
tdiff =
1
m
·
N∑
i=1
Yi · Ti − 1
N −m ·
N∑
i=1
Yi · (1− Ti)
=
1
m
·
N∑
i=1
Ti · Yi(0) + SATT− 1
N −m ·
N∑
i=1
Yi(0) · (1− Ti)
=
1
m
·
N∑
i=1
Ti · Yi(0)− 1
N −m ·
N∑
i=1
Yi(0) · (1− Ti) + SATT
=
N
m · (N −m) ·
N∑
i=1
Yi(0)Ti − 1
N −m ·
N∑
i=1
Yi(0)︸ ︷︷ ︸
constant
+ SATT (34)
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The decomposition of tdiff as a function of Y (1) and the SATC can be proved using a similar
proof to the one above.
C Proof of Lemma 2
The variance of tdiff − SATE can be written as,
Var (tdiff − SATE) = m
N · (N −m)σ
2
0 +
N −m
N ·m σ
2
1 +
2
N
· ρ · σ0 · σ1
=
p
N · (1− p) · σ
2
0 +
N · (1− p)
N2 · p · σ
2
1 +
2
N
· ρ · σ0 · σ1
=
p
N · (1− p) · σ
2
0 +
(1− p)
N · p · σ
2
1 +
2
N
· ρ · σ0 · σ1
=
1
N · (1− p) · p ·
[
p2 · σ20 + (1− p)2 · σ21 + 2p(1− p) · ρ · σ0 · σ1
]
The variance derivations of tdiff − SATT are described in E, and the variance calculation of tdiff −
SATC follows exactly the same steps as the variance calculation of tdiff − SATT.
D Proof of Theorem 4.1
Proof of part (1) of Theorem 4.1
The proof is a simple implementation of the intermediate value theorem. We show that the
difference in variance is negative when ρ = −1, and is positive when ρ = 1, and that the difference
in variance is a continuous and increasing function with respect to ρ. Then the desired result
follows immediately from the intermediate value theorem.
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When ρ = −1, the variance of tdiff − SATE can be written as:
Var (tdiff − SATE) = m
N · (N −m)σ
2
0 +
N −m
N ·m σ
2
1 +
2
N
· ρ · σ0 · σ1
=
p
N · (1− p) · σ
2
0 +
N · (1− p)
N2 · p · σ
2
1 −
2
N
· σ0 · σ1
=
p
N · (1− p) · σ
2
0 +
(1− p)
N · p · σ
2
1 −
2
N
· σ0 · σ1
=
1
N · (1− p) · p ·
[
p2 · σ20 + (1− p)2 · σ21 − 2p(1− p) · σ0 · σ1
]
=
1
N · (1− p) · p · (p · σ0 − (1− p) · σ1)
2
and as,
p · σ0 < σ0 − (1− p) · σ1 < σ0
it follows that when ρ = −1, then Var (tdiff − SATE) < Var (tdiff − SATT). When ρ = 1, the
variance of tdiff − SATE can be written as:
Var (tdiff − SATE) = p
N · (1− p) · σ
2
0 +
N · (1− p)
N2 · p · σ
2
1 +
2
N
· σ0 · σ1
=
p
N · (1− p) · σ
2
0 +
(1− p)
N · p · σ
2
1 +
2
N
· σ0 · σ1
=
1
N · (1− p) · p ·
[
p2 · σ20 + (1− p)2 · σ21 + 2p(1− p) · σ0 · σ1
]
=
1
N · (1− p) · p · (p · σ0 + (1− p) · σ1)
2
and as σ1 > σ0, it follows immediately that when ρ = 1, Var (tdiff − SATE) > Var (tdiff − SATT).
As ∂Var(tdiff−SATE)−Var(tdiff−SATT)
∂ρ
> 0, it follows directly from the intermediate value theorem
that there exists a value of ρ, ρ¯, such that:
ρ ≤ ρ¯⇒ Var (tdiff − SATE) ≤ Var (tdiff − SATT)
ρ > ρ¯⇒ Var (tdiff − SATE) > Var (tdiff − SATT)
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Proof of part (2) of Theorem 4.1
Consider the case in which ρ = 0:
Var (tdiff − SATE) = 1
N · (1− p) · p ·
[
p2 · σ20 + (1− p)2 · σ21
]
Var (tdiff − SATT) will be lower than Var (tdiff − SATE), when:
p2 · σ20 + (1− p)2 · σ21 ≥ σ20 ⇒
(1− p)2
1− p2 · σ
2
1 ≥ σ20
Note, (1−p)
2
1−p2 =
1+p2−2p
1−p2 ≤ 1 ⇒ p2 − 2p ≤ −p2 ⇒ 2p2 ≤ 2p ⇒ p2 ≤ p, which is always satisfied.
Therefore, 0 ≤ (1−p)2
1−p2 ≤ 1. To conclude, when σ1σ0 >
√
1−p2
(1−p)2 the variance difference will be positiv
Var (tdiff − SATE) > Var (tdiff − SATT). As the variance difference is negative when ρ = −1 it
follows directly from the intermediate value theorem that the desired ρ¯ exists and is strictly larger
than −1 and lower than 0 — ρ¯ is negative. This concludes the proof.
E Proof of Theorem 4.4
According to Lemma 1, the adjusted difference in means, N−m
N
· (tdiff − SATT), has the same
distribution of 1
m
·∑Ni=1 Yi(0) · Ti with an additive shift of 1N ·∑Ni=1 Yi(0). ?, ?, ?, and Li and Ding
(2016) all provide proofs showing that in a finite population model with complete randomization
the standardized mean of the treated (or sampled) units will follow a standard Normal distribution
under two regularity conditions,
N −m→∞, and m→∞ (35)
and
max
1≤i≤N
(
Y (0)Ni − Y¯ (0)N
)2
∑N
i=1
(
Y (0)Ni − Y¯ (0)N
)2 ·max(N −mm , mN −m
)
→∞ (36)
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The expectation and variance of N−m
N
· (tdiff − SATT) are derived next and complete the proof
of (4.2). The expectation is,
E
[
N −m
N
· (tdiff − SATT)
]
=
N −m
N
·
[
N
m(N −m) ·
N∑
i=1
E [Y (0)] · E [T ]− 1
N
·
N∑
i=1
E [Y (0)]
]
=
N
m
· E [Y (0)] · m
N
−− 1
N
·N · E [Y (0)]
= 0
where the first equality follows from Lemma 1. The variance of the adjusted difference in means
is,
Var
(
N −m
N
· (tdiff − SATT)
)
= Var
(
1
m
·
N∑
i=1
Yi(0) · Ti − 1
N
·
N∑
i=1
Yi(0)
)
=
1
m2
· Var
(
·
N∑
i=1
Yi(0) · Ti
)
where the first equality follows from Lemma 1, and the second equality follows as 1
N
·∑Ni=1 Yi(0)
is a constant and not a random variable. The variance of the sum
∑N
i=1 Yi(0) · Ti, is the variance
of m units who are randomly sampled from the population YN1(0), . . . , YNN(0).
7 Denote the m
chosen variables by V1, . . . , Vm, and the variance of the sum V1 + · · ·+ Vm is,
Var (V1 + · · ·+ Vm) =
m∑
i=1
Var (Vi) +
m∑
i=1
∑
j 6=i
Cov (Vi, Vj) = m · σ20 +m(m− 1) · ρ (37)
where the second equality follows as the covariance between each two units is the same and is
denoted by ρ. When m = N , the variance of the sum is zero and therefore,
ρ = − σ
2
0
N − 1 (38)
7Our calculation of the variance of 1N ·
∑N
i=1 Yi(0) follows the variance calculation of the Wilcoxon Rank Sum
Test statistic in ?.
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Substituting (38) in (37) and re-arranging yields that:
Var
(
N −m
N
· (tdiff − SATT)
)
= Var
(
1
m
·
N∑
i=1
Yi(0) · Ti − 1
N
·
N∑
i=1
Yi(0)
)
=
1
m2
· Var
(
·
N∑
i=1
Yi(0) · Ti
)
=
1
m2
· m(N −m)
N − 1 · σ
2
0
=
N −m
m(N − 1) · σ
2
0
≈ N −m
mN
· σ20 =
(
1
m
− 1
N
)
· σ20
Hence, it follows that:
Var ((tdiff − SATT)) =
(
N
N −m
)2
· Var
(
N −m
N
· (tdiff − SATT)
)
=
(
N
N −m
)2
·
(
N −m
mN
)
· σ20
=
N
(N −m) ·m · σ
2
0
=
1
Np(1− p) · σ
2
0
F Proof of Theorem (4.3)
The first part of the theorem, that [p · LSATT + (1− p) · LSATC, p · USATT + (1− p) · USATC], fol-
lows immediately from the proof of Theorem (1) in Rigdon and Hudgens (2015). Next we show
the derivations of the second part of the theorem.
p · LSATT + (1− p) · LSATC = tdiff − z1−α/2 ·
√
k(N,m) · (pσ0 + (1− p)σ1)
= tdiff − z1−α/2 ·
√
k(N,m) ·
√
Vˆρ=1
37
and
p · USATT + (1− p) · USATC = tdiff + z1−α/2 ·
√
k(N,m) · (pσ0 + (1− p)σ1)
= tdiff + z1−α/2 ·
√
k(N,m) ·
√
Vˆρ=1
The second equality in both of the above equations follows from substituting ρ = 1 in the variance
formula for Var (tdiff − SATE) in Lemma (2).
G Proof of Theorem 4.4
The desired result follows immediately from a comparison of the different variance expressions in
Lemma 2.
H Super-population model
H.1 Proof of Lemma 4
Var (tdiff − PATE) = Var (tdiff) = σ
2
0(SP)
N −m +
σ21(SP)
m
see Imbens and Rubin (2015) for proof.
Next we derive the variance of tdiff − SATE:
Var (tdiff − SATE) = E
[
(tdiff − SATE)2
]− (tdiff − SATE)2
= E
[
(tdiff − SATE)2
]
= E
[
t2diff
]
+ E
[
SATE2
]− 2 · E [tdiff · SATE]
= E
[
t2diff
]
+ E
[
SATE2
]− 2 · (Var (SATE) + PATE2)
= Var (tdiff) + Var (SATE)− 2 · Var (SATE)
= Var (tdiff)− Var (SATE)
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Note that,
E [tdiff · SATE] = ESP [ET [tdiff · SATE| (Y(1),Y(0))]]
= ESP
[
SATE2
]
= Var (SATE) + [ESP [SATE]]2
= Var (SATE) + PATE2
The variance of SATE is:
Var (SATE) =
1
N
· Var (Yi(1)− Yi(0)) = 1
N
· (σ21(SP) + σ20(SP)− 2ρ(SP)σ1(SP)σ0(SP))
Therefore the Var (tdiff − SATE) is:
Var (tdiff − SATE) = 1
m
· σ21(SP) +
1
N −m · σ
2
0(SP)−
1
N
· (σ21(SP) + σ20(SP)− 2ρ(SP)σ1(SP)σ0(SP))
=
N −m
Nm
· σ21(SP) +
m
(N −m)N · σ
2
0(SP) +
2ρ(SP)σ1(SP)σ0(SP)
N
=
1− p
Np
· σ21(SP) +
p
N(1− p) · σ
2
0(SP) +
2ρ(SP)σ1(SP)σ0(SP)
N
=
1
Np(1− p) ·
[
(1− p)2 · σ21(SP) + p2 · σ20(SP)
]
+
2ρ(SP)σ1(SP)σ0(SP)
N
=
1
N · (1− p) · p ·
[
p2 · σ20(SP) + (1− p)2 · σ21(SP) + 2p(1− p) · ρ(SP) · σ0(SP) · σ1(SP)
]
Next we derive the variance of tdiff − SATT under the super-population model.
39
Var
(
N −m
N
· (tdiff − SATT)
)
= E Y(1),Y(0)
[
VarT
(
N −m
N
· (tdiff − SATT) |Y (1), Y (0)
)]
+ VarY(1),Y(0)
(
E T
[
N −m
N
· (tdiff − SATT) |Y (1), Y (0)
])
= E Y(1),Y(0)
[
VarT
(
N −m
N
· (tdiff − SATT) |Y (1), Y (0)
)]
= E Y(1),Y(0)
[
N −m
m(N − 1) · σ
2
0(FS)
]
=
N −m
m(N − 1) · E Y(1),Y(0)
[
σ20(FS)
]
=
N −m
m(N − 1) · σ
2
0(SP)
where the first equality follows from the law of total variance (i.e., law of conditional variance).
There are a few more technical steps to complete the derivation. We neglect them as they already
appeared in detail in Appendix C. The calculation of the variance of tdiff− SATC is similar to the
one above.
I Proof: Variance of (tdiff − SATO)
Consider the following class of average treatment effect estimands:
SATO = ω · SATT + (1− ω) · SATC (39)
We discuss inferences on this class of estimands using the difference-in-means test statistic.
Var (tdiff − SATO) = Var (tdiff) + Var (SATO)− 2 · Cov (SATO, tdiff)
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According to the derivations that are detailed later on in this section we can re-write the variance
of tdiff re-centered w.r.t SATO as:
Var (tdiff − SATO) = 1
Np(1− p)
[
p2σ20 + (1− p)2σ21 + 2p(1− p) · ρσ0σ1
]
+
σ2τ
N − 1 ·
[
ω2 · 1− p
p
+ (1− ω)2 · p
1− p − 2ω(1− ω)
]
− 2 ·
[
ω
(N − 1)p
[
σ21 − ρσ1σ0
]− 1
N − 1 · σ
2
τ +
(1− ω)
(N − 1)(1− p)
[
σ20 − ρσ1σ0
]]
Calculation of Var (SATO)
Var (SATO) = ω2 · Var (SATT) + (1− ω)2 · Var (SATC)− 2 · ω(1− ω) · Cov (SATT, SATC)
= ω2 · N −m
m(N − 1) · σ
2
τ + (1− ω)2 ·
m
(N −m)(N − 1) · σ
2
τ − ω(1− ω) ·
2
N − 1 · σ
2
τ
=
σ2τ
N − 1 ·
[
ω2 · 1− p
p
+ (1− ω)2 · p
1− p − 2ω(1− ω)·
]
Calculation of Cov (SATO, tdiff)
The covariance term is:
Cov
(
ω · SATT + (1− ω) · SATC, N
m · (N −m) ·
N∑
i=1
Yi(0) · Ti − 1
N −m ·
N∑
i=1
Yi(0) + SATT
)
= ω · N
m · (N −m) · Cov
(
SATT,
N∑
i=1
Yi(0) · Ti
)
+ ω · Var (SATT)
+ (1− ω) · N
m · (N −m) · Cov
(
SATC,
N∑
i=1
Yi(0) · Ti
)
+ (1− ω) · Cov (SATC, SATT)
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According to the derivations that are described in detail later on in this section we can re-write
the above covariance expression as:
Cov (SATO, tdiff) = ω · N
m · (N −m) ·
(1− p)N
N − 1 ·
[
ρσ1σ0 − σ20
]
+ ω · N −m
m(N − 1) · σ
2
τ
− (1− ω) · N
m(N −m) ·
m
N − 1 ·
[
ρσ1σ0 − σ20
]− (1− ω) · 1
N − 1 · σ
2
τ
= ω · 1
p(N − 1) ·
[
ρσ1σ0 − σ20
]
+ ω · (1− p)
p(N − 1) · σ
2
τ −
1
N − 1(1− ω)σ
2
τ
− (1− ω)
(N − 1)(1− p)
[
ρσ1σ0 − σ20
]
=
ω
(N − 1)p
[
ρσ1σ0 − σ20 + (1− p)σ2τ + pσ2τ
]− 1
N − 1 · σ
2
τ
− (1− ω)
(N − 1)(1− p)
[
ρσ1σ0 − σ20
]
=
ω
(N − 1)p
[
σ21 − ρσ1σ0
]− 1
N − 1 · σ
2
τ −
(1− ω)
(N − 1)(1− p)
[
ρσ1σ0 − σ20
]
Calculation of Var (SATT) and Var (SATC)
Var (SATT) =
N −m
m(N − 1) · σ
2
τ =
N −m
m(N − 1) ·
[
σ21 + σ
2
0 − 2ρ · σ1 · σ0
]
Similarly,
Var (SATC) =
m
(N −m)(N − 1) · σ
2
τ
Calculation of Cov
(
SATC,
∑N
i=1 Yi(0) · Ti
)
Cov
(
SATC,
N∑
i=1
Yi(0) · Ti
)
= − m
N −m · Cov
(
SATT,
N∑
i=1
Yi(0) · Ti
)
= − m
N −m ·
(1− p)N
N − 1 ·
[
ρσ1σ0 − σ20
]
= − m
N − 1 ·
[
ρσ1σ0 − σ20
]
≈ −p · [ρσ1σ0 − σ20]
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where the second equality follows from the derivations in the next subsection below.
Calculation of Cov
(
SATT,
∑N
i=1 Yi(0) · Ti
)
Cov
(
SATT,
N∑
i=1
Yi(0) · Ti
)
=
1
m
· Cov
(
N∑
i=1
Yi(1) · Ti −
N∑
i=1
Yi(0) · Ti,
N∑
i=1
Yi(0) · Ti
)
=
1
m
·
[
Cov
(
N∑
i=1
Yi(1) · Ti,
N∑
i=1
Yi(0) · Ti
)
− Var
(
N∑
i=1
Yi(0) · Ti
)]
=
1
m
·
[
p(1− p)N2
N − 1 · ρ · σ1σ0 −
m(N −m)
N − 1 · σ
2
0
]
=
(1− p)N
N − 1 ·
[
ρσ1σ0 − σ20
]
Derivations of Cov
(∑N
i=1 Yi(1) · Ti,
∑N
i=1 Yi(0) · Ti
)
E
[
N∑
l=1
Yl(1) · Tl ·
N∑
i=1
Yi(0) · Ti
]
= E
[
N∑
i=1
N∑
l=1
Yl(1) · Yi(0) · Ti · Tl
]
= E
[
Ti ·
N∑
i=1
Yi(0) · Yi(1) +
N∑
i=1
∑
l 6=i
Yi(0) · Yl(1) · Ti · Tl
]
= Pr(Ti = 1) ·
N∑
i=1
Yi(0) · Yi(1) + E [Ti · Tl|i 6= l] ·
N∑
i=1
∑
l 6=i
Yi(0) · Yl(1)
=
m
N
·
N∑
i=1
Yi(0) · Yi(1) + m
N
· m− 1
N − 1 ·
N∑
i=1
∑
l 6=i
Yi(0) · Yl(1)
=
m
N
· N −m
N − 1 ·
N∑
i=1
Yi(0) · Yi(1) + m
N
· m− 1
N − 1 ·
N∑
i=1
N∑
l=1
Yi(0) · Yl(1)
E
[
N∑
l=1
Yl(1) · Tl
]
=
m
N
N∑
l=1
Yl(1)
E
[
N∑
l=1
Yl(0) · Tl
]
=
m
N
N∑
l=1
Yl(0)
⇒ E
[
N∑
l=1
Yl(1) · Tl
]
· E
[
N∑
i=1
Yl(0) · Ti
]
=
(m
N
)2
·
N∑
i=1
N∑
l=1
Yi(0) · Yl(1)
43
Hence,
Cov
(
N∑
i=1
Yi(1) · Ti,
N∑
i=1
Yi(0) · Ti
)
=
m
N
·
[
N −m
N − 1 ·
N∑
i=1
Yi(0) · Yi(1)− N −m
N(N − 1) ·
N∑
i=1
N∑
l=1
Yi(0) · Yl(1)
]
=
m
N
· N −m
N − 1 ·
[
N∑
i=1
Yi(0) · Yi(1)− 1
N
·
N∑
i=1
N∑
l=1
Yi(0) · Yl(1)
]
=
p(1− p)N
N − 1 ·
[
N∑
i=1
Yi(0) · Yi(1)− 1
N
·
N∑
i=1
N∑
l=1
Yi(0) · Yl(1)
]
Re-arranging the above expression yields:
Cov
(
N∑
i=1
Yi(1) · Ti,
N∑
i=1
Yi(0) · Ti
)
=
p(1− p)N2
N − 1 · ρ · σ1σ0
Calculation of Cov (SATT, SATC)
Note that the covariance between SATT and SATC is,
Cov (SATT, SATC) = Cov
(
1
m
·
N∑
i=1
(Yi(1)− Yi(0)) · Ti, 1
N −m ·
N∑
i=1
(Yi(1)− Yi(0)) · (1− Ti)
)
= − 1
m
· 1
N −m · Cov
(
N∑
i=1
(Yi(1)− Yi(0)) · Ti,
N∑
i=1
(Yi(1)− Yi(0))Ti
)
= − 1
N · p(1− p) ·
Var
(∑N
i=1(Yi(1)− Yi(0))Ti
)
N
= − 1
N · p(1− p) ·
m2
N
· Var (SATT)
= − 1
N · p(1− p) ·
m2
N
· N −m
m(N − 1) · σ
2
τ
= − 1
N − 1 · σ
2
τ
Another way of deriving the covariance between the SATT and SATC is to use the fact that
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Var (SATE) = 0: First note that,
Var (SATE) = Var
(m
N
· SATT
)
+ Var
(
N −m
N
· SATC
)
+ 2 · p(1− p) · Cov (SATT, SATC)
= p2 · 1
m2
· Var
(
N∑
i=1
(Yi(1)− Yi(0))Ti
)
+ (1− p)2 · 1
(N −m)2 · Var
(
N∑
i=1
(Yi(1)− Yi(0))Ti
)
+ 2 · p(1− p) · Cov (SATT, SATC)
= 2 · 1
N2
· Var
(
N∑
i=1
(Yi(1)− Yi(0))Ti
)
+ 2 · p(1− p) · Cov (SATT, SATC)
Hence,
Var (SATE) = 0
⇒ Cov (SATT, SATC) = − 1
N · p(1− p) ·
Var
(∑N
i=1(Yi(1)− Yi(0))Ti
)
N
J Proof of Theorem (7.1)
As both m and
∑N
i=1 Yi(0) · Ti are random variables, the distribution of the ratio can be derived
using the Delta method. The result that the limiting distribution is Normal follows directly from
standard results of the Delta method (?). The derivations of the variance-covariance matrix of the
limiting distribution are detailed below. First notice that:
1
N
·
N∑
i=1
Yi(0) · Ti p→ E [Y (0)]
1
N
·
N∑
i=1
Yi(0) · Ti d→ N
(
E [Y (0)] ,
1
N
· p(1− p) [σ20 + E [Y (0)]2])
where
Var
(
1
N
·
N∑
i=1
Yi(0) · Ti
)
=
1
N2
· p(1− p)
N∑
i=1
Yi(0)
2
=
1
N
· p(1− p) [σ20 + E [Y (0)]2]
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and that m follows a Binomial distribution of m ∼ Binom(n, p) and the variance of m is Var (m) =
N · p(1− p). The covariance between m and ∑Ni=1 Yi(0) · Ti is
Cov
(
m,
N∑
i=1
Yi(0) · Ti
)
= Cov
(
N∑
i=1
Ti,
N∑
i=1
Yi(0) · Ti
)
=
N∑
i=1
Yi(0) · Var (Ti)
= p(1− p) ·
N∑
i=1
Yi(0)
= p(1− p) ·N · E [Y (0)]
and therefore the covariance-variance matrix is,
Σ =
 N · p(1− p) [σ20 + E [Y (0)]2] p(1− p) ·N · E [Y (0)]
p(1− p) ·N · E [Y (0)] N · p(1− p)
 (40)
The variance of 1
m
·∑Ni=1 Yi(0) · Ti is,
 1m
−
∑N
i=1 Yi(0)·Ti
m2

T
· Σ ·
 1m
−
∑N
i=1 Yi(0)·Ti
m2

where a consistent estimator for p is 1
N
·∑Ni=1 Ti and a consistent estimator for ∑Ni=1 Yi(0) · Ti is∑N
i=1 Yi(0) · (1− Ti).
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